These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6839956)

  • 21. Drug dosage in renal disease.
    Dettli L
    Clin Pharmacokinet; 1976; 1(2):126-34. PubMed ID: 797495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug metabolites in renal failure: pharmacokinetic and clinical implications.
    Verbeeck RK; Branch RA; Wilkinson GR
    Clin Pharmacokinet; 1981; 6(5):329-45. PubMed ID: 7037261
    [No Abstract]   [Full Text] [Related]  

  • 23. Multiple dose kinetics and drug dosage in patients with kidney disease.
    Dettli L; Spring P; Ryter S
    Acta Pharmacol Toxicol (Copenh); 1971; 29 Suppl 3():211-24. PubMed ID: 5316403
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of methoxy groups in the NI-substituent of sulfonamides on the pathways of elimination in man. The acetylation-deacetylation equilibrium and mechanisms of renal excretion of sulfisomidine, sulfamethomidine and sulfadimethoxine.
    Vree TB; Hekster YA; Tijhuis MW; Baakman M; Oosterbaan MJ; Termond EF
    Pharm Weekbl Sci; 1984 Aug; 6(4):150-6. PubMed ID: 6483571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of the elimination kinetics of torasemide, a novel loop diuretic, in renal insufficiency.
    Dodion L; Willems JL
    Eur J Clin Pharmacol; 1986; 31 Suppl():49-51. PubMed ID: 3780839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Procainamide elimination kinetics in pediatric patients.
    Singh S; Gelband H; Mehta AV; Kessler K; Casta A; Pickoff AS
    Clin Pharmacol Ther; 1982 Nov; 32(5):607-11. PubMed ID: 7128001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of age, renal function and heart failure on procainamide clearance and n-acetylprocainamide serum concentrations.
    Bauer LA; Black D; Gensler A; Sprinkle J
    Int J Clin Pharmacol Ther Toxicol; 1989 May; 27(5):213-6. PubMed ID: 2472362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of Lidaprim in cases of impaired renal function.
    Hitzenberger G; Korn A; Pichler H; Bonelli J; Magometschnigg D
    Int J Clin Pharmacol Biopharm; 1977 Jul; 15(7):310-4. PubMed ID: 892947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole in children and adults with normal and impaired renal function.
    Siber GR; Gorham CC; Ericson JF; Smith AL
    Rev Infect Dis; 1982; 4(2):566-78. PubMed ID: 6981173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pharmacokinetics of slow-release procainamide.
    Tilstone WJ; Lawson DH; Campbell W; Hutton I; Lawrie TD
    Eur J Clin Pharmacol; 1978 Dec; 14(4):261-5. PubMed ID: 729620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Skin penetration of sulfamethoxazole and trimethoprim after oral administration].
    Królicki A
    Ann Acad Med Stetin; 2002; 48():59-73. PubMed ID: 14601469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of metronidazole in patients with varying degrees of renal failure.
    Houghton GW; Dennis MJ; Gabriel R
    Br J Clin Pharmacol; 1985 Feb; 19(2):203-9. PubMed ID: 3986078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simple integrated method for drug and derived metabolite kinetics. An application of the statistical moment theory.
    Chan KK
    Drug Metab Dispos; 1982; 10(5):474-9. PubMed ID: 6183086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of vinpocetine and apovincaminic acid in patients with impaired renal function.
    Miskolczi P; Vereczkey L; Szalay L; Göndöcs CS
    Eur J Drug Metab Pharmacokinet; 1984; 9(2):169-75. PubMed ID: 6745306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consequences of renal insufficiency on the hepatic clearance of some drugs.
    Balant LP; Dayer P; Fabre J
    Int J Clin Pharmacol Res; 1983; 3(6):459-74. PubMed ID: 6147317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacokinetics of trimethoprim and sulfametrol in patients with end stage renal failure and hemodialysis treatment (author's transl)].
    Schmidt P; Korn A; Hitzenberger G; Zazgornik J; Kopsa H; Pils P
    Wien Med Wochenschr; 1980 Feb; 130(4):171-3. PubMed ID: 7376686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of procainamide hydrochloride in dogs.
    Papich MG; Davis LE; Davis CA; McKiernan BC; Brown SA
    Am J Vet Res; 1986 Nov; 47(11):2351-8. PubMed ID: 2431636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose and concentration dependent effect of ranitidine on procainamide disposition and renal clearance in man.
    Somogyi A; Bochner F
    Br J Clin Pharmacol; 1984 Aug; 18(2):175-81. PubMed ID: 6091709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of naproxen in subjects with normal and impaired renal function.
    Anttila M; Haataja M; Kasanen A
    Eur J Clin Pharmacol; 1980 Oct; 18(3):263-8. PubMed ID: 7439246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical pharmacokinetics of procainamide.
    Karlsson E
    Clin Pharmacokinet; 1978; 3(2):97-107. PubMed ID: 346289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.